SOLVASOL INJECTION

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

Active ingredient:

CEFALEXIN (AS CEFALEXIN SODIUM)

Available from:

Norbrook Laboratories Limited

ATC code:

QJ01DB01

INN (International Name):

CEFALEXIN (AS CEFALEXIN SODIUM)

Dosage:

180 Mg/Ml

Pharmaceutical form:

Suspension for Injection

Prescription type:

POM

Therapeutic group:

Bovine, Canine

Therapeutic area:

Cefalexin

Therapeutic indications:

Antibacterial

Authorization status:

Authorised

Authorization date:

2002-06-14

Summary of Product characteristics

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Solvasol Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substance
Cefalexin
180 mg
(as cefalexin sodium)
Base
to 1 ml
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Suspension for injection.
An off-white to cream oily suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle and Dogs
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of infections caused by, or associated with organisms sensitive to cefalexin in cattle and dogs.
When susceptible organisms are present, Solvasol Injection is indicated in the treatment of infections of the respiratory
tract, urogenital tract, the skin and localised infections in soft tissues in dogs. In dogs it may also be effective in the
treatment of infections of the gastrointestinal tract.
4.3 CONTRAINDICATIONS
Do not use in known cases of hypersensitivity to cephalosporins.
Do not inject intravenously or intrathecally.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 14/11/2016_
_CRN 7023649_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Accumulation may occur when renal function is impaired. Use with caution in cases of known renal insufficiency.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE PRODUCT TO ANIMALS
Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin
contact. Hypersensitivity to penicillins may lead to cross reactions to cephalosporins and vice versa. Allergic reactions to
these substances may occasionally be serious.
Do not handle thi
                                
                                Read the complete document
                                
                            

Search alerts related to this product